Skip to content

TENAX THERAPEUTICS, INC.: filings

Every TENAX THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-31fiscal Q2 202628820001193125-26-327455
10-Q2026-05-12fiscal Q1 202628580001193125-26-219383
10-K2026-03-10fiscal FY 202532650001193125-26-099393
10-Q2025-11-12fiscal Q3 202532930001193125-25-277793
10-Q2025-08-13fiscal Q2 202532900000950170-25-108063
10-Q2025-05-14fiscal Q1 202530610000950170-25-071395
10-K2025-03-25fiscal FY 202435700000950170-25-044398
10-Q2024-11-13fiscal Q3 202426800001654954-24-014262
10-Q2024-08-13fiscal Q2 202424700001654954-24-010456
10-Q2024-05-14fiscal Q1 202423500001654954-24-006228
10-K2024-03-28fiscal FY 202329600001654954-24-003827
10-Q2023-11-13fiscal Q3 202326800001654954-23-014168
10-Q2023-08-14fiscal Q2 202328800001654954-23-010758
10-Q2023-05-15fiscal Q1 202327580001654954-23-006566
10-K2023-03-31fiscal FY 202231640001654954-23-003945
10-Q2022-11-10fiscal Q3 202229860001654954-22-015030
10-Q2022-08-11fiscal Q2 202229810001654954-22-011073
10-Q2022-05-16fiscal Q1 202228590001654954-22-006980
10-K2022-03-29fiscal FY 202131640001654954-22-004036
10-Q2021-11-15fiscal Q3 202131870001568276-21-002533
10-Q2021-08-16fiscal Q2 202130840001654954-21-009088
10-Q2021-05-17fiscal Q1 202130620001654954-21-005892
10-K/A2021-04-16fiscal FY 202033680001654954-21-004297
10-K2021-03-31fiscal FY 202033680001654954-21-003641
10-Q2020-11-16fiscal Q3 202031820001654954-20-012485
10-Q2020-08-14fiscal Q2 202031820001654954-20-009183
10-Q2020-05-15fiscal Q1 202030620001654954-20-005647
10-K2020-03-30fiscal FY 201932660001654954-20-003498
10-Q2019-11-14fiscal Q3 201931900001654954-19-013001
10-Q2019-08-14fiscal Q2 201931860001654954-19-009589
10-Q2019-05-15fiscal Q1 201931660001654954-19-006116
10-K2019-04-01fiscal FY 201831630001654954-19-003861
10-Q2018-11-14fiscal Q3 201829760001654954-18-012742
10-Q2018-08-14fiscal Q2 201829760001654954-18-009137
10-Q2018-05-15fiscal Q1 201829600001654954-18-005454
10-K2018-04-02fiscal FY 201730620001654954-18-003517
10-Q2017-11-09fiscal Q3 201730800001654954-17-010320
10-Q2017-08-09fiscal Q2 201730800001654954-17-007141
10-Q2017-05-10fiscal Q1 201729600001654954-17-004348
10-K2017-03-16fiscal FY 2016401270001654954-17-002098
10-Q2016-11-09fiscal Q3 201633880001654954-16-003694
10-Q2016-08-09fiscal Q2 201631800001654954-16-001314
10-Q2016-05-10fiscal Q1 201633680001354488-16-007294
10-Q2015-12-10fiscal Q2 201634900001354488-15-005479
10-Q2015-09-09fiscal Q1 201634700001354488-15-004246
10-K2015-07-14fiscal FY 201543880001354488-15-003333
10-Q2015-03-17fiscal Q3 2015431220001354488-15-001191
10-Q2014-12-15fiscal Q2 2015431220001354488-14-006182
10-Q2014-09-15fiscal Q1 201543870001354488-14-004652
10-K2014-07-29fiscal FY 201443860001354488-14-003782
10-Q2014-03-17fiscal Q3 2014421350001354488-14-001188
10-Q2013-12-17fiscal Q2 2014411330001354488-13-006923
10-Q2013-09-17fiscal Q1 201440980001354488-13-005278
10-K2013-06-26fiscal FY 201340970001354488-13-003629
10-Q2013-03-18fiscal Q3 2013391220001354488-13-001297
10-Q2012-12-14fiscal Q2 2013391220001354488-12-006449
10-Q2012-09-19fiscal Q1 201337900001354488-12-004961
10-K2012-07-25fiscal FY 201234860001354488-12-003634
10-Q2012-03-15fiscal Q3 2012341110001354488-12-001166
10-Q2011-12-15fiscal Q2 2012341110001354488-11-005021
10-Q2011-09-19fiscal Q1 201233830001354488-11-003481

Inspect the source

Entity
TENAX THERAPEUTICS, INC. / CIK 0000034956
Captured
2026-09-19T14:46:45.117Z
SEC response SHA-256
3f4f90f5f823d316ffb20bc63506ae090888657f5ff1cb9568439e153f028cf5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000034956.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))